Lipella Pharmaceuticals I... (LIPO)
2.96
-0.11 (-3.58%)
At close: Jan 15, 2025, 3:58 PM
2.90
-2.01%
After-hours Jan 15, 2025, 05:15 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Revenue | 449.62K | 184.16K | 259.35K | 961.68K | 694.75K |
| Cost of Revenue | 3.04M | 2.55M | 1.46M | 975.96K | 682.89K |
| Gross Profit | -2.59M | -2.36M | -1.20M | -14.28K | 11.86K |
| Operating Income | -4.75M | -2.59M | -1.92M | -56.86K | -53.79K |
| Interest Income | 137.84K | 1.68K | 104.00 | 3.17K | 334.00 |
| Pretax Income | -4.62M | -2.60M | -1.87M | -61.66K | -61.85K |
| Net Income | -4.62M | -2.60M | -1.87M | -66.45K | -61.85K |
| Selling & General & Admin | 2.16M | 226.19K | 718.38K | 42.59K | 65.65K |
| Research & Development | 3.04M | 2.55M | 1.46M | 975.96K | 682.89K |
| Other Expenses | n/a | -45 | 57.09K | n/a | n/a |
| Operating Expenses | 2.16M | 2.77M | 2.18M | 1.02M | 748.54K |
| Interest Expense | 10.85K | 9.61K | 6.83K | 7.96K | 8.39K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 5.20M | 2.77M | 2.18M | 1.02M | 748.54K |
| Income Tax | n/a | -1.63K | 6.73K | 4.79K | -53.79K |
| Shares Outstanding (Basic) | 750.38K | 5.74M | 5.74M | 5.69M | 5.69M |
| Shares Outstanding (Diluted) | 6.00M | 5.74M | 5.74M | 5.69M | 5.69M |
| EPS (Basic) | -6.16 | -0.45 | -0.33 | -0.01 | -0.01 |
| EPS (Diluted) | -0.77 | -0.45 | -0.33 | -0.01 | -0.01 |
| EBITDA | -4.61M | -2.59M | n/a | -53.69K | 334.00 |
| Depreciation & Amortization | 1.69K | 2.59M | 1.92M | 56.86K | 53.79K |